Literature DB >> 8755560

Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity.

J A Rankin1, D E Picarella, G P Geba, U A Temann, B Prasad, B DiCosmo, A Tarallo, B Stripp, J Whitsett, R A Flavell.   

Abstract

To investigate the contribution of interleukin-4 (IL-4) to airway inflammation in vivo and to explore directly its relationship to airway reactivity, we created transgenic mice in which the murine cDNA for IL-4 was regulated by the rat Clara cell 10 protein promoter. Expression was detected only in the lung and not in thymus, heart, liver, spleen, kidney, or uterus. The expression of IL-4 elicited hypertrophy of epithelial cells of the trachea, bronchi, and bronchioles. Hypertrophy is due, at least in part, to the accumulation of mucus glycoprotein. Histologic examination of parenchyma revealed multinucleated macrophages and occasional islands of cells consisting largely of eosinophils or lymphocytes. Analysis of lung lavage fluid revealed the presence of a leukocytic infiltrate consisting of lymphocytes, neutrophils and eosinophils. Mice expressing IL-4 had greater baseline airway resistance but did not demonstrate hyperreactivity to methacholine. Thus, the expression of IL-4 selectively within the lung elicits an inflammatory response characterized by epithelial cell hypertrophy, and the accumulation of macrophages, lymphocytes, eosinophils, and neutrophils without resulting in an alteration in airway reactivity to inhaled methacholine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755560      PMCID: PMC38832          DOI: 10.1073/pnas.93.15.7821

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Interleukin-5, eosinophils, and disease.

Authors:  C J Sanderson
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

2.  Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines.

Authors:  S Z Ben-Sasson; G Le Gros; D H Conrad; F D Finkelman; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 3.  Airway epithelial cells: functional roles in airway disease.

Authors:  S I Rennard; D J Romberger; J H Sisson; S G Von Essen; I Rubinstein; R A Robbins; J R Spurzem
Journal:  Am J Respir Crit Care Med       Date:  1994-11       Impact factor: 21.405

4.  Comparative morphologic features of bronchiolar epithelial cells. The Clara cell.

Authors:  C G Plopper
Journal:  Am Rev Respir Dis       Date:  1983-08

5.  Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.

Authors:  B F DiCosmo; G P Geba; D Picarella; J A Elias; J A Rankin; B R Stripp; J A Whitsett; R A Flavell
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.

Authors:  A W Cheever; M E Williams; T A Wynn; F D Finkelman; R A Seder; T M Cox; S Hieny; P Caspar; A Sher
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

7.  Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.

Authors:  A Zlotnik; M Fischer; N Roehm; D Zipori
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Pulmonary responses to bronchoconstrictor agonists in the mouse.

Authors:  T R Martin; N P Gerard; S J Galli; J M Drazen
Journal:  J Appl Physiol (1985)       Date:  1988-06

9.  Distinct functional phenotypes of cloned Ia-restricted helper T cells.

Authors:  J Kim; A Woods; E Becker-Dunn; K Bottomly
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Interleukin 4 expressed in situ selectively alters thymocyte development.

Authors:  D B Lewis; C C Yu; K A Forbush; J Carpenter; T A Sato; A Grossman; D H Liggitt; R M Perlmutter
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  97 in total

Review 1.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Activation of the transforming growth factor beta pathway in bacterial otitis media.

Authors:  Yun-Woo Lee; Yunju Chung; Steven K Juhn; Youngki Kim; Jizhen Lin
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-03       Impact factor: 1.547

Review 3.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 4.  Transgenic modelling of cytokine polarization in the lung.

Authors:  Charles S Dela Cruz; Min-Jong Kang; Won-Kyung Cho; Chun Geun Lee
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

Review 5.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

Review 6.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 7.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

8.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The cationic amino acid transporter 2 is induced in inflammatory lung models and regulates lung fibrosis.

Authors:  Kathryn A Niese; Monica G Chiaramonte; Lesley G Ellies; Marc E Rothenberg; Nives Zimmermann
Journal:  Respir Res       Date:  2010-06-24

Review 10.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.